NEW YORK, Sept 29 – Bioinformatics company Genomica (Nasdaq: GNOM) said Friday it had priced its initial public offering of 6,440,000 shares of common stock on the Nasdaq at $19.00 per share.

Gross proceeds from the offering, the latest in a string of bioinformatics IPOs, are expected to be $122.4 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.